Castleark Management’s Inspire Medical Systems INSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-32,190
Closed -$10.5M 298
2023
Q2
$10.5M Sell
32,190
-7,260
-18% -$2.07M 0.47% 41
2023
Q1
$9.23M Hold
39,450
0.45% 41
2022
Q4
$9.94M Buy
39,450
+6,330
+19% +$1.35M 0.52% 44
2022
Q3
$5.87M Sell
33,120
-750
-2% -$151K 0.33% 68
2022
Q2
$6.19M Buy
33,870
+4,430
+15% +$883K 0.33% 63
2022
Q1
$7.56M Buy
+29,440
New +$6.73M 0.33% 71
2021
Q1
Sell
-9,238
Closed -$1.74M 350
2020
Q4
$1.74M Sell
9,238
-49,008
-84% -$8.01M 0.07% 203
2020
Q3
$7.52M Sell
58,246
-35,032
-38% -$3.86M 0.29% 102
2020
Q2
$8.12M Sell
93,278
-18,910
-17% -$1.45M 0.35% 75
2020
Q1
$6.76M Sell
112,188
-18,710
-14% -$1.38M 0.4% 69
2019
Q4
$9.71M Sell
130,898
-51,653
-28% -$3.32M 0.39% 78
2019
Q3
$11.1M Buy
182,551
+200
+0.1% +$13.2K 0.45% 66
2019
Q2
$11.1M Buy
182,351
+62,268
+52% +$3.36M 0.42% 76
2019
Q1
$6.82M Sell
120,083
-2,172
-2% -$117K 0.26% 127
2018
Q4
$5.17M Buy
+122,255
New +$5.2M 0.22% 140

Other funds holding INSP

Castleark Management's INSP Position: Q3 2023 in Review

Castleark Management sold out of Inspire Medical Systems (INSP) in Q3 2023, closing a stake of 32,190 shares — an estimated $10.5M sold.

Castleark Management first reported a position in INSP in Q4 2018 and held it in 15 quarters. The position peaked at $11.1M in Q3 2019. 364 funds tracked by Wall St. Rank hold INSP as of Q3 2023.

  • Castleark Management reported no remaining Inspire Medical Systems position as of Q3 2023 after selling out during the quarter.
  • Castleark Management sold 32,190 Inspire Medical Systems shares in Q3 2023, an estimated $10.5M.
  • Castleark Management first reported a position in Inspire Medical Systems in Q4 2018 and held it in 15 quarters.
  • Castleark Management's Inspire Medical Systems position peaked at $11.1M in Q3 2019.
  • 364 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q3 2023.

Based on Castleark Management's 13F filing for Q3 2023, filed 15 Nov 2023.